Cargando…

Small Molecule c-KIT Inhibitors for the Treatment of Gastrointestinal Stromal Tumors: A Review on Synthesis, Design Strategies, and Structure–Activity Relationship (SAR)

The proto-oncogenic protein, c-KIT, plays a crucial role in regulating cellular transformation and differentiation processes, such as proliferation, survival, adhesion, and chemotaxis. The overexpression of, and mutations, in c-KIT can lead to its dysregulation and promote various human cancers, par...

Descripción completa

Detalles Bibliográficos
Autores principales:	Godesi, Sreenivasulu, Lee, Joohan, Nada, Hossam, Quan, Guofeng, Elkamhawy, Ahmed, Choi, Yongseok, Lee, Kyeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253927/ https://www.ncbi.nlm.nih.gov/pubmed/37298401 http://dx.doi.org/10.3390/ijms24119450

Ejemplares similares

Integration of Hybridization Strategies in Pyridine–Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic Insights
por: Godesi, Sreenivasulu, et al.
Publicado: (2023)

Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment
por: Godesi, Sreenivasulu, et al.
Publicado: (2023)

Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer
por: Nada, Hossam, et al.
Publicado: (2021)

The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
por: Elkamhawy, Ahmed, et al.
Publicado: (2021)

Machine Learning-Based Approach to Developing Potent EGFR Inhibitors for Breast Cancer—Design, Synthesis, and In Vitro Evaluation
por: Nada, Hossam, et al.
Publicado: (2023)

Identification of 1H-purine-2,6-dione derivative as a potential SARS-CoV-2 main protease inhibitor: molecular docking, dynamic simulations, and energy calculations
por: Nada, Hossam, et al.
Publicado: (2022)

Hit Identification of a Novel Quinazoline Sulfonamide as a Promising EphB3 Inhibitor: Design, Virtual Combinatorial Library, Synthesis, Biological Evaluation, and Docking Simulation Studies
por: Lee, Kyeong, et al.
Publicado: (2021)

Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor Activity
por: Elsherbeny, Mohamed H., et al.
Publicado: (2021)

C-Kit-Negative Gastrointestinal Stromal Tumor in the Stomach
por: Seo, Ho Seok, et al.
Publicado: (2015)

Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies
por: Elkamhawy, Ahmed, et al.
Publicado: (2022)

4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies
por: Nada, Hossam, et al.
Publicado: (2022)

Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
por: Huang, Mengyuan, et al.
Publicado: (2019)

Cantharidin-Based Verbenone Derivatives as a Novel Insecticide against Plutella xylostella: Design, Synthesis, Insecticidal Activity Evaluation, and 3D QSAR Study
por: Lee, Kwanshik, et al.
Publicado: (2023)

Frequent KIT Mutations in Human Gastrointestinal Stromal Tumors
por: Xu, Zhi, et al.
Publicado: (2014)

Gastrointestinal stromal tumor with KIT mutation in neurofibromatosis type 1
por: Namgung, Hwan
Publicado: (2011)

Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors
por: Caenepeel, Sean, et al.
Publicado: (2010)

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
por: Katz, Steven C, et al.
Publicado: (2013)

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
por: Ke, Hengning, et al.
Publicado: (2016)

KCTD12 is negatively regulated by Kit in gastrointestinal stromal tumors
por: Suehara, Yoshiyuki, et al.
Publicado: (2018)

Morphological Correlates of KIT and PDGFRA Genotypes in Gastrointestinal Stromal Tumour
por: Priya, Valli, et al.
Publicado: (2020)

Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors
por: Gao, Jing, et al.
Publicado: (2016)

Spectrum of the KIT Gene Mutations in Gastrointestinal Stromal Tumors in Arab Patients
por: Faiyaz-Ul-Haque, Muhammad, et al.
Publicado: (2018)

KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors
por: Palomba, Grazia, et al.
Publicado: (2020)

Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor
por: Jiang, Lili, et al.
Publicado: (2021)

Enhanced Bioavailability of AC1497, a Novel Anticancer Drug Candidate, via a Self-Nanoemulsifying Drug Delivery System
por: Baral, Kshitis Chandra, et al.
Publicado: (2021)

Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors
por: Hsueh, Yuan-Shuo, et al.
Publicado: (2019)

Gastrointestinal Stromal Tumors with KIT Mutation Coexisting with Wild-type Gastrointestinal Stromal Tumors in a Patient with Neurofibromatosis Type 1
por: Li, Yang, et al.
Publicado: (2018)

Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules
por: Vallilas, Christos, et al.
Publicado: (2021)

Gastrointestinal Stromal Tumours treated before and after the advent of c-kit immunostaining
por: Sorelli, Paolo G, et al.
Publicado: (2011)

A Case of KIT-Negative Extra-Gastrointestinal Stromal Tumor of the Lesser Omentum
por: Ogawa, Hisataka, et al.
Publicado: (2012)

Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor
por: Zhang, Dengyang, et al.
Publicado: (2022)

Mutational Analysis of c-KIT and PDGFRA in Canine Gastrointestinal Stromal Tumors (GISTs)
por: Morini, Maria, et al.
Publicado: (2022)

Involvement of c-KIT mutation in the development of gastrointestinal stromal tumors through proliferation promotion and apoptosis inhibition
por: Ma, Ying-Yu, et al.
Publicado: (2014)

The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting
por: Maleddu, Alessandra, et al.
Publicado: (2011)

Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors
por: Merkelbach-Bruse, Sabine, et al.
Publicado: (2010)

Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis
por: Zong, Liang, et al.
Publicado: (2014)

Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumors
por: Pantaleo, Maria A, et al.
Publicado: (2014)

ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours
por: Gromova, Petra, et al.
Publicado: (2012)

Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors
por: Rossi, Sabrina, et al.
Publicado: (2016)

C‐kit Gene Abnormalities in Gastrointestinal Stromal Tumors (Tumors of Interstitial Cells of Cajal)
por: Sakurai, Shinji, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_4cqj3bk7t2ujsjmftgi5v5pgho